Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AstraZeneca
Pharma
AZ, GSK make case for broad I-O uses in endometrial cancer
For AstraZeneca's and GSK's PD-(L)1/PARP regimens, the contribution of a PARP drug in a subset of endometrial cancer patients have come into question.
Angus Liu
Mar 18, 2024 11:05am
AstraZeneca caps out-of-pocket inhaler costs at $35 in the US
Mar 18, 2024 11:02am
Merck claims digital crown, holding off challenge from AZ, BMS
Mar 15, 2024 10:30am
PhRMA seeks to revive IRA lawsuit, blasts Biden's SOTU update
Mar 8, 2024 8:57am
AstraZeneca pledges £650M in UK to expand manufacturing, R&D
Mar 6, 2024 11:38am
Drugmakers counter HHS' first offers in Medicare price talks
Mar 4, 2024 4:09pm